Does Smaller AUM Equal Less Compensation?
The Thelander surveys are constantly evolving to keep up with the ever-changing market. We are excited to announce that our total assets under management (AUM) filter has expanded to include the lower categories of: Less than $25 million, $25 – $49.9 million, $50 – $99.9 million, $100 – $249.9 million… all the way up to $7 billion […]
Does Stage of Development Impact Compensation for Biotech Companies?
For our August newsletter, we look at data from biotech companies to see how stage of development impacts compensation for its CEOs. The different stages of development can be categorized into five groups:1) Pre-Clinical 2) First in Man 3) FDA Clinical Trial Phase I 4) FDA Clinical Trial Phase II 5) Commercial Chart 1 shows the median for total cash, founder, and non-founder equity for CEOs […]